Page last updated: 2024-09-03

doridosine and 5-iodotubercidin

doridosine has been researched along with 5-iodotubercidin in 1 studies

Compound Research Comparison

Studies
(doridosine)
Trials
(doridosine)
Recent Studies (post-2010)
(doridosine)
Studies
(5-iodotubercidin)
Trials
(5-iodotubercidin)
Recent Studies (post-2010) (5-iodotubercidin)
1400140042

Protein Interaction Comparison

ProteinTaxonomydoridosine (IC50)5-iodotubercidin (IC50)
Chain A, Mitogen-activated protein kinase 3Homo sapiens (human)0.9
Mitogen-activated protein kinase 1Homo sapiens (human)1.2
Adenosine kinaseHomo sapiens (human)0.1583
Adenosine kinaseMycobacterium tuberculosis H37Rv1.2
Dual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)0.071
Histone-lysine N-methyltransferase, H3 lysine-79 specificHomo sapiens (human)7

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baird-Lambert, J; Davies, LP; Marwood, JF1

Other Studies

1 other study(ies) available for doridosine and 5-iodotubercidin

ArticleYear
Studies on several pyrrolo[2,3-d]pyrimidine analogues of adenosine which lack significant agonist activity at A1 and A2 receptors but have potent pharmacological activity in vivo.
    Biochemical pharmacology, 1986, Sep-15, Volume: 35, Issue:18

    Topics: Adenosine; Adenosine Deaminase; Adenosine Kinase; Adenosine-5'-(N-ethylcarboxamide); Animals; Blood Pressure; Brain; Cyclic AMP; Guanosine; Guinea Pigs; Heart Rate; Male; Mice; Muscle Relaxation; Phenylisopropyladenosine; Receptors, Cell Surface; Receptors, Purinergic; Tubercidin

1986